Health ProductsType I recall

PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg: NDMA and NNORT impurity

· Published by Health Canada · Official notice

Details

Alert type: Health product recall
Category: Health products - Drugs
Product: PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg
Issue: Health products - Contamination
What to do: Consult your health care professional if you have any health concerns.
Audience: General public, Healthcare, Industry
Recall class: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

BrandLotProduct NameMarket AuthorizationDosage FormStrength
PMS-AMITRIPTYLINE 50 mg634972
635465
637195
637532
PMS-AMITRIPTYLINE 50 mgDIN 00654507TabletAmitriptyline Chlorhydrate 50 mg
PMS-AMITRIPTYLINE 10 mg635484
638600
636906
636907
648428
648429
633439
632625
632626
633440
636905
636146
636749
634973
635485
PMS-AMITRIPTYLINE 10 mgDIN 00654523TabletAmitriptyline Chlorhydrate 10 mg
PMS-AMITRIPTYLINE 25 mg635435
633433
632775
635482
PMS-AMITRIPTYLINE 25 mgDIN 00654515TabletAmitriptyline Chlorhydrate 25 mg

Issue

Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT) or exceed the acceptable cumulative intake limit for (N-nitrosodimethylamine (NDMA) and NNORT).

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime